Facet Logo     Abbott Investor Relations
Abbott Careers
Contact
   
 
 
         

We are committed to creating better treatments             to help patients live better lives

 
  Pipeline
Overview
Daclizumab
Elotuzumab (HuLuc63)
TRU-016
Volociximab (M200)
PDL192
  Pipeline Daclizumab
  Relevant Link
Phase 3 Study in Multiple Sclerosis
Proposed Mechanism of Action

CHOICE Presentation